Should You Buy Rocket Lab Stock Ahead of the SpaceX IPO?

Rocket Lab is highlighted as the second-most-used launch company in the U.S., with a $2.2 billion backlog and a $190 million U.S. government contract for 20 HASTE hypersonic test flights over four years. The article also points to its expanding space systems business and upcoming Neutron rocket as catalysts, while the looming SpaceX IPO is increasing investor attention on the space economy. Overall tone is positive but largely promotional, with limited near-term trading impact.

Analysis

The market is likely treating this as a broader re-rating event for the private space ecosystem, but the first-order beneficiary is not just RKLB beta — it is the public analog for de-risked government spend plus vertically integrated components. The important second-order effect is that a high-profile SpaceX listing may force investors to re-underwrite launch economics across the group: if the market assigns a premium multiple to SpaceX on strategic scarcity, smaller public names can either rerate as “optionality” or get discounted as structurally less efficient. That sets up a dispersion trade, not a simple thematic long.

RKLB’s real asset is not launch; it is program capture with recurring component content and a backlog that can convert into multi-year revenue visibility. The medium-term catalyst is Neutron, but the binary risk is execution slippage because every quarter of delay pushes the company back into a story stock regime where sentiment outruns fundamentals. The government contract angle matters more than headline launch cadence: defense demand can cushion cash burn, but only if the company continues to win work that is less price-sensitive than commercial launches.

The contrarian point is that a SpaceX IPO could compress the valuation implied for every adjacent player if investors conclude the category leader is now investable directly. In that case, RKLB may underperform on a relative basis even if the absolute sector trade stays bid. The setup is therefore asymmetric: good news from SpaceX can be bullish for the theme, but also create a higher bar for RKLB to justify premium multiples unless Neutron timing and margin conversion are clean over the next 2-3 quarters.

Key Decisions for Investors

• Long RKLB into event-driven volatility, but only on pullbacks: build 1/3 position now and add on any post-hype retracement over the next 2-6 weeks; target is theme rerating, stop if Neutron timing slips materially or backlog conversion stalls.
• Pair trade: long RKLB / short a basket of lower-quality pre-revenue space names if available; this expresses the view that capital will concentrate in the most credible public operator rather than the broad theme.
• If listed SpaceX becomes tradable, reduce RKLB exposure into strength and rotate into the relative value dislocation between strategic scarcity and execution risk; expect 10-20% short-term multiple compression in RKLB if the IPO absorbs incremental thematic inflows.
• Use call spreads on RKLB rather than outright equity for a 3-6 month catalyst window; the setup is headline-sensitive and upside can be captured with limited premium outlay while capping downside if the market de-risks the sector.
• Watch defense contract follow-through over the next 1-2 quarters; if HASTE-related awards and adjacent government wins continue, add on confirmation because that is the cleaner driver of durable valuation support than launch-cycle sentiment.